Login / Signup
PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
Xiaoni Sun
Luyi Chai
Bingjie Wang
Jianbo Zhou
Published in:
Archives of oral biology (2024)
PRELP suppressed OSCC progression via inactivation of the NF-κB pathway. Targeting PRELP may be a potential approach for OSCC treatment.
Keyphrases
</>
signaling pathway
lps induced
pi k akt
oxidative stress
nuclear factor
inflammatory response
cell proliferation
risk assessment
human health
immune response
drug delivery
climate change